KALA BIO, Inc.

KALA
$0.63 (+ $0.02 + 3.97%)
Last updated: 2026-07-25 04:38 UTC
KALA Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS4831191030
CUSIP483119103
Market Price0.63
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-5.64
Market Cap$6.9M
Book Value-1.17
Price to Book-0.549
Beta-2.51
52w High20.6
52w Low0.51
Next Earnings DateN/A

KALA BIO, Inc. trades under ticker KALA on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US4831191030, CUSIP 483119103. Also searched as KALA BIO.

Related researchKALA stock priceKALA share priceKALA BIO stockKALA BIO share price483119103
About the Company
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Price History